Stephen Feider - 27 Feb 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Reporting relationship: Chief Financial Officer
Issuer ticker: BBNX
Reported as of: 27 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2025, 17:45:08 UTC
Prior SEC filing: 03 Feb 2025
Next SEC filing: 04 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Stephen Feider

Key filing fact

Stephen Feider filed Form 4 for Beta Bionics, Inc. (BBNX) on 03 Mar 2025.

Key facts

This page summarizes Stephen Feider's Form 4 filing for Beta Bionics, Inc. (BBNX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2025, 17:45.

Change

Previous filing in this sequence was filed on 03 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BBNX transaction

Common Stock

Award

Transaction value: $0
Shares: +47,000
Change %
Price: $0.000000
Shares after: 47,000
Date: 27 Feb 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BBNX transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +71,000
Change %
Price: $0.000000
Shares after: 71,000
Date: 27 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 71,000
Exercise price: $19.91
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

Footnote F2

The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .